IL58579A - Nitrogen heterocyclic compounds,their preparation and pharmaceutical compositions containing them - Google Patents

Nitrogen heterocyclic compounds,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL58579A
IL58579A IL58579A IL5857979A IL58579A IL 58579 A IL58579 A IL 58579A IL 58579 A IL58579 A IL 58579A IL 5857979 A IL5857979 A IL 5857979A IL 58579 A IL58579 A IL 58579A
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
heterocyclic compounds
nitrogen heterocyclic
Prior art date
Application number
IL58579A
Other languages
English (en)
Other versions
IL58579A0 (en
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of IL58579A0 publication Critical patent/IL58579A0/xx
Publication of IL58579A publication Critical patent/IL58579A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/90Oxygen atoms with acyclic radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL58579A 1978-10-31 1979-10-29 Nitrogen heterocyclic compounds,their preparation and pharmaceutical compositions containing them IL58579A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7842679 1978-10-31
GB7920760 1979-06-14

Publications (2)

Publication Number Publication Date
IL58579A0 IL58579A0 (en) 1980-01-31
IL58579A true IL58579A (en) 1985-12-31

Family

ID=26269406

Family Applications (1)

Application Number Title Priority Date Filing Date
IL58579A IL58579A (en) 1978-10-31 1979-10-29 Nitrogen heterocyclic compounds,their preparation and pharmaceutical compositions containing them

Country Status (32)

Country Link
US (1) US4419352A (es)
AR (1) AR230449A1 (es)
AT (1) AT379811B (es)
AU (1) AU528648B2 (es)
BR (1) BR7907006A (es)
CA (1) CA1142520A (es)
CH (1) CH643264A5 (es)
CS (1) CS231166B2 (es)
CU (1) CU21123A (es)
DD (1) DD146954A5 (es)
DE (1) DE2943658A1 (es)
DK (1) DK458679A (es)
FI (1) FI67702C (es)
FR (1) FR2440371A1 (es)
GR (1) GR73861B (es)
HK (1) HK66185A (es)
HU (1) HU183087B (es)
IE (1) IE49464B1 (es)
IL (1) IL58579A (es)
KE (1) KE3540A (es)
LU (1) LU81841A1 (es)
MA (1) MA18631A1 (es)
MY (1) MY8500439A (es)
NL (1) NL7907916A (es)
NO (1) NO154522C (es)
NZ (1) NZ191956A (es)
PH (1) PH15442A (es)
PL (1) PL130691B1 (es)
PT (1) PT70392A (es)
SE (1) SE451071B (es)
SG (1) SG40885G (es)
SU (1) SU1014476A3 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260306A (en) * 1981-07-24 1993-11-09 Fisons Plc Inhalation pharmaceuticals
GB8402047D0 (en) * 1984-01-26 1984-02-29 Fisons Plc Nitrogen heterocycles
EP0162556B1 (en) * 1984-04-13 1991-11-06 FISONS plc Novels forms and formulations of nedocromil sodium
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
EP0279121B1 (en) * 1986-12-23 1993-09-01 FISONS plc Pharmaceutical compositions comprising an aqueous solution of a pyranoquinoline derivative
USRE38628E1 (en) * 1986-12-23 2004-10-19 Fisons Plc Pharmaceutical compositions
USH672H (en) 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
US4767612A (en) * 1987-01-23 1988-08-30 Rorer Pharmaceutical Corporation Triamcinolone acetonide for the treatment of allergic rhinitis
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
GB2202145B (en) * 1987-03-17 1991-01-02 Fisons Plc Compositions of nedocromil for dermatological use.
US5648084A (en) * 1990-02-28 1997-07-15 Guttag; Alvin Multiple dosage medicine drop bottle
AU650036B2 (en) * 1990-07-25 1994-06-09 Teijin Limited Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5453431A (en) * 1993-10-29 1995-09-26 Gilman; Andrew L. Use of hydroxychloroquine for treatment of graft-versus-host disease
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
US5891472A (en) * 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
US5989571A (en) * 1997-07-23 1999-11-23 Millenium Pharmaceutical Technologies, Inc. Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory
US5885550A (en) * 1998-07-02 1999-03-23 Vallier; Deandra K. Ophthalmic whitening solution
US7101547B1 (en) 1999-01-22 2006-09-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies
AU2001264616A1 (en) * 2000-05-17 2001-11-26 Cor Therapeutics, Inc. Methods for producing amino substituted chromanes and intermediates therefor
US9132116B2 (en) * 2004-08-02 2015-09-15 Willowcroft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis
GB0524808D0 (en) * 2005-12-05 2006-01-11 Novartis Ag Organic compounds
DE102007028095A1 (de) * 2007-06-19 2009-01-15 Bachmann, Vincent Zubereitung zur Behandlung von Hufrehe bei Equiden
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
EP2424527B8 (en) * 2009-04-29 2019-07-17 Willowcraft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1504709A (en) * 1974-12-07 1978-03-22 Fisons Ltd N-substituted quinolinone-2-carboxyl. acid der
AU513456B2 (en) * 1977-03-08 1980-12-04 Takeda Chemical Industries Ltd. l-Azaxanthone-3-carboxylic acids
IL54614A (en) * 1977-05-04 1983-07-31 Fisons Ltd Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CS735979A2 (en) 1984-02-13
PL130691B1 (en) 1984-08-31
HK66185A (en) 1985-09-13
DK458679A (da) 1980-05-01
AU5228779A (en) 1980-05-08
FI67702B (fi) 1985-01-31
AU528648B2 (en) 1983-05-05
US4419352A (en) 1983-12-06
LU81841A1 (fr) 1980-05-07
DD146954A5 (de) 1981-03-11
SU1014476A3 (ru) 1983-04-23
NZ191956A (en) 1984-05-31
NL7907916A (nl) 1980-05-02
IL58579A0 (en) 1980-01-31
AR230449A1 (es) 1984-04-30
GR73861B (es) 1984-05-08
SG40885G (en) 1986-05-02
AT379811B (de) 1986-03-10
PL219304A1 (es) 1980-12-01
PT70392A (en) 1979-11-01
NO154522B (no) 1986-06-30
CH643264A5 (fr) 1984-05-30
KE3540A (en) 1985-07-12
FR2440371A1 (fr) 1980-05-30
DE2943658A1 (de) 1980-05-14
PH15442A (en) 1983-01-18
DE2943658C2 (es) 1991-08-01
SE7908995L (sv) 1980-05-01
CS231166B2 (en) 1984-10-15
FI67702C (fi) 1985-05-10
NO793469L (no) 1980-05-02
CA1142520A (en) 1983-03-08
HU183087B (en) 1984-04-28
IE792074L (en) 1980-04-30
CU21123A (es) 1982-08-28
NO154522C (no) 1986-10-08
FI793369A (fi) 1980-05-01
MY8500439A (en) 1985-12-31
ATA701479A (de) 1985-07-15
IE49464B1 (en) 1985-10-16
FR2440371B1 (es) 1983-01-28
MA18631A1 (fr) 1980-07-01
SE451071B (sv) 1987-08-31
BR7907006A (pt) 1980-07-15

Similar Documents

Publication Publication Date Title
IL58579A (en) Nitrogen heterocyclic compounds,their preparation and pharmaceutical compositions containing them
DE2963320D1 (en) Ergoline compounds, their preparation and pharmaceutical compositions containing them
IL57708A0 (en) Aminopropoxyindole derivatives,their preparation and pharmaceutical compositions containing them
DE3163938D1 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IL57040A (en) Imidazole derivatives,their preparation and pharmaceutical compositions containing them
IL61264A (en) Dihydro-piperazinylpyrazolobenzodiazepine compounds,their preparation and pharmaceutical compositions containing them
DE2862404D1 (en) Hydantoin derivatives, their preparation and pharmaceutical compositions containing them
IL60472A0 (en) Substituted heterocyclic phenoxy-amines,their preparation and pharmaceutical compositions containing them
IL57297A (en) 4-amino-2-piperidinoquinazoline derivatives,their preparation and pharmaceutical compositions containing them
DE2963350D1 (en) Heterocyclic carboxamidine compounds, their preparation and pharmaceutical compositions containing them
IL60813A0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IL58620A (en) Aryltrifluoroethanol derivatives,their preparation and pharmaceutical compositions containing them
IL56816A0 (en) N-phenylaniline derivatives,their preparation and pharmaceutical compositions containing them
IL61580A0 (en) Heterocyclic compound,its preparation and pharmaceutical compositions containing it
IL56913A (en) Sprio-steroid-oxazolidinone derivatives,their preparation and pharmaceutical compositions containing them
IL56890A0 (en) 2-amino-carbazole derivatives,their preparation and pharmaceutical compositions containing them
DE2963868D1 (en) Carbostyrile derivatives, their preparation and pharmaceutical compositions containing them
IL56075A0 (en) Novel arylaminoimidazoline derivatives,their preparation and pharmaceutical compositions containing them
ZA7930B (en) 3-aminopropoxyaryl derivatives,their preparation and pharmaceutical compositions containing them
KE3749A (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL56529A0 (en) Azathianaphthalene derivatives, their manufacture and pharmaceutical compositions containing them
IL59396A0 (en) Penicillin derivatives,their preparation and pharmaceutical compositions containing them
IL56962A (en) Substituted n-iminomethyl-piperidines,their preparation and pharmaceutical compositions containing them
IL58815A (en) Omega-aminoalkoxyiminocyclododecane derivatives,their preparation and pharmaceutical compositions containing them
IL57780A0 (en) Propiophenoneamine derivatives,their preparation and pharmaceutical compositions containing them